Reticular Pseudodrusen (RPD)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Reticular Pseudodrusen (RPD) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedEarly Phase 1

NCT03478878

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

Background: Age-related macular degeneration (AMD) is an eye disease. It is the leading cause of vision loss in people over 55 in the U.S. Changes in the eye c…

United States9 participantsStarted 2018-05-14

Treatment: Vitamin A Palmitate